Banning colistin in feed additives: a small step in the right direction.

Lancet Infect Dis

Aix Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille 13005, France. Electronic address:

Published: January 2021

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(20)30915-4DOI Listing

Publication Analysis

Top Keywords

banning colistin
4
colistin feed
4
feed additives
4
additives small
4
small step
4
step direction
4
banning
1
feed
1
additives
1
small
1

Similar Publications

Antimicrobial resistance (AMR) is a significant global health threat, with multidrug-resistant (MDR) bacterial clones becoming a major concern. Polymyxins, especially colistin, have reemerged as last-resort treatments for MDR Gram-negative infections. However, colistin use in livestock has spread mobile colistin resistance () genes, notably , impacting human health.

View Article and Find Full Text PDF

Introduction: Gaps in antimicrobial resistance (AMR) surveillance and control, including implementation of national action plans (NAPs), are evident internationally. Countries' capacity to translate political commitment into action is crucial to cope with AMR at the human-animal-environment interface.

Methods: We employed a two-stage process to understand opportunities and challenges related to AMR surveillance and control at the human-animal interface in Argentina.

View Article and Find Full Text PDF

The surveillance of antimicrobial resistance (AMR) in commensal from livestock at slaughter is widely employed to assess the potential for risk to humans. There is currently a limited understanding of AMR in Bangladesh poultry at retail in live bird markets, with studies focussing solely on phenotypic characterisation of resistance. To address this evidence gap we performed antimicrobial susceptibility testing and whole genome sequencing on obtained from chickens from live bird markets in Dhaka in 2018 ( = 38) and 2020 ( = 45).

View Article and Find Full Text PDF

Background: Antimicrobial resistance (AMR) is a global health problem largely due to the overuse of antimicrobials. In recognition of this, the World Health Assembly in 2015 agreed on a global action plan to tackle AMR. Following the global emergence of the mcr-1-associated colistin resistance gene in the livestock industry in 2016, several countries including South Africa restricted the veterinary use of colistin as the gene threatens the clinical utility of the drug.

View Article and Find Full Text PDF

Background And Aim: Colistin is used to treat avian pathogenic (APEC), a microorganism that affects turkey meat production in the Gaza Strip and worldwide. However, the recent emergence of plasmid-borne mobile colistin resistance () genes in pathogenic strains is a serious antimicrobial resistance (AMR) challenge for both human and animal health. In December 2018, colistin was banned as a veterinary antimicrobial in the Gaza Strip.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!